MD1009Z - Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma - Google Patents

Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma

Info

Publication number
MD1009Z
MD1009Z MDS20150029A MDS20150029A MD1009Z MD 1009 Z MD1009 Z MD 1009Z MD S20150029 A MDS20150029 A MD S20150029A MD S20150029 A MDS20150029 A MD S20150029A MD 1009 Z MD1009 Z MD 1009Z
Authority
MD
Moldova
Prior art keywords
susceptibility
person
development
hodgkin lymphoma
determining
Prior art date
Application number
MDS20150029A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Ион МЕРЕУЦЭ
Алёна НИКОРИЧ
Валентина СТРАТАН
Original Assignee
Алёна НИКОРИЧ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алёна НИКОРИЧ filed Critical Алёна НИКОРИЧ
Priority to MDS20150029A priority Critical patent/MD1009Z/en
Publication of MD1009Y publication Critical patent/MD1009Y/en
Publication of MD1009Z publication Critical patent/MD1009Z/en

Links

Abstract

The invention relates to medicine, in particular to hematology and can be used for determining the susceptibility of a person to the development of non-Hodgkin lymphoma.According to the invention, the method consists in the fact that persons in whom is determined the Arg/Arg genotype of the XRCC1 gene codon is additionally determined the ratio of IgM and IgG immunoglobulins and where the ratio is 0.03…0.24, it is established the person's susceptibility to the development of non-Hodgkin lymphoma.
MDS20150029A 2015-03-02 2015-03-02 Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma MD1009Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20150029A MD1009Z (en) 2015-03-02 2015-03-02 Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20150029A MD1009Z (en) 2015-03-02 2015-03-02 Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma

Publications (2)

Publication Number Publication Date
MD1009Y MD1009Y (en) 2016-02-29
MD1009Z true MD1009Z (en) 2016-09-30

Family

ID=55447203

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20150029A MD1009Z (en) 2015-03-02 2015-03-02 Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma

Country Status (1)

Country Link
MD (1) MD1009Z (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD280C2 (en) * 1993-03-17 1996-01-31 Онкологический Институт Республики Молдова Method of treatment of upper extremity lymphostase and the device for its achievement
MD1367C2 (en) * 1992-11-13 2000-11-30 Idec Pharmaceuticals Corporation Methods of B-cells lymphoma treatment, anti-CD20 antibodies, hybridoma
RU2211695C2 (en) * 2001-10-08 2003-09-10 Ростовский научно-исследовательский онкологический институт Method for treating non-hodgkin's lymphomas
RU2007115763A (en) * 2007-04-25 2008-10-27 Государственное образовательное учреждение высшего профессионального образования Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НГМУ Росздрава) (RU) METHOD FOR FORECASTING THE EFFECTIVENESS OF LYMPH THERAPY
RU2373862C1 (en) * 2008-04-07 2009-11-27 Государственное образовательное учреждение высшего профессионального образования Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НГМУ Росздрава) Method of determining person's predisposaition to development of aggressive non-hodgkin's lymphomas
RU2490641C1 (en) * 2012-08-01 2013-08-20 Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" Method for prediction of clinical course of non-hodgkin lymphomas
RU2490638C1 (en) * 2012-08-01 2013-08-20 Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" Method for prediction of developing b cell and t cell non-hodgkin lymphomas
RU2012108895A (en) * 2012-03-07 2013-11-20 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации METHOD FOR FORECASTING THE COURSE OF MALIGNANT LYMPHOMAS

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1367C2 (en) * 1992-11-13 2000-11-30 Idec Pharmaceuticals Corporation Methods of B-cells lymphoma treatment, anti-CD20 antibodies, hybridoma
MD280C2 (en) * 1993-03-17 1996-01-31 Онкологический Институт Республики Молдова Method of treatment of upper extremity lymphostase and the device for its achievement
RU2211695C2 (en) * 2001-10-08 2003-09-10 Ростовский научно-исследовательский онкологический институт Method for treating non-hodgkin's lymphomas
RU2007115763A (en) * 2007-04-25 2008-10-27 Государственное образовательное учреждение высшего профессионального образования Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НГМУ Росздрава) (RU) METHOD FOR FORECASTING THE EFFECTIVENESS OF LYMPH THERAPY
RU2373862C1 (en) * 2008-04-07 2009-11-27 Государственное образовательное учреждение высшего профессионального образования Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НГМУ Росздрава) Method of determining person's predisposaition to development of aggressive non-hodgkin's lymphomas
RU2012108895A (en) * 2012-03-07 2013-11-20 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации METHOD FOR FORECASTING THE COURSE OF MALIGNANT LYMPHOMAS
RU2490641C1 (en) * 2012-08-01 2013-08-20 Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" Method for prediction of clinical course of non-hodgkin lymphomas
RU2490638C1 (en) * 2012-08-01 2013-08-20 Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" Method for prediction of developing b cell and t cell non-hodgkin lymphomas

Also Published As

Publication number Publication date
MD1009Y (en) 2016-02-29

Similar Documents

Publication Publication Date Title
NZ753515A (en) Methods for treatment of cancer comprising tigit-binding agents
SV2018005678A (en) ANTIBODY THAT NEUTRALIZES THE HUMAN SYNTHETIC RESPIRATORY VIRUS
MX2023000781A (en) Humanized, mouse or chimeric anti-cd47 monoclonal antibodies.
SG11201906780SA (en) Bcma-targeting antibody and use thereof
NZ738008A (en) Tigit-binding agents and uses thereof
PH12018500707A1 (en) Anti-human cd19 antibodies with high affinity
NZ741129A (en) Anti-pd1 antibodies and methods of use
NZ739252A (en) Monoclonal antibodies against bcma
TN2016000559A1 (en) Monoclonal antibodies against her2 epitope and methods of use thereof
NZ739750A (en) Anti-tigit antibodies and methods of use
EA201992546A1 (en) MEANS ON THE BASIS OF ANTIBODIES TO CD33
CY1122456T1 (en) MONOCLONAL ANTIBODIES AGAINST GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15), AND USES THEREOF FOR THE THERAPEUTIC TREATMENT OF CANCER CACHESIS AND CANCER
WO2016100985A3 (en) Chimeric antigen receptors and methods of use thereof
MA40576B1 (en) Anti-her2 antibodies and immunoconjugates
MY197441A (en) Antibodies targeting fc receptor-like 5 and method of use
UA120948C2 (en) New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
MX2017016169A (en) Anti-her2 antibodies and methods of use.
MX2013009679A (en) Anti-il-6 receptor antibodies and methods of use.
PH12018500887A1 (en) Anti-htra1 antibodies and methods of use thereof
MX370191B (en) Compositions and methods for the treatment of immunodeficiency.
MA39248B1 (en) Anti-jagged1 antibodies and methods of use thereof
NZ741067A (en) Bispecific anti-human cd20/human transferrin receptor antibodies and methods of use
EP3411504A4 (en) Anti-tnf antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
FI3615066T3 (en) Formulations of human anti-rankl antibodies, and methods of using the same
TN2013000472A1 (en) Induction of immune tolerance by using methotrexate

Legal Events

Date Code Title Description
FG9Y Short term patent issued
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)